Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy

47Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.

Abstract

Glioblastoma multiforme (GBM) is a common, usually lethal disease with a median survival of only ~15 months. It has proven resistant in clinical trials to chemotherapeutic agents such as paclitaxel that are highly effective in vitro, presumably because of impaired drug delivery across the tumor's blood-brain barrier (BBB). In an effort to increase paclitaxel delivery across the tumor BBB, we linked the drug to a novel filomicelle nanocarrier made with biodegradable poly(ethyleneglycol)- block-poly(e-caprolactone-r-D,L-lactide) and used precisely collimated radiation therapy (RT) to disrupt the tumor BBB's permeability in an orthotopic mouse model of GBM. Using a non-invasive bioluminescent imaging technique to assess tumor burden and response to therapy in our model, we demonstrated that the drugloaded nanocarrier (DLN) alone was ineffective against stereotactically implanted intracranial tumors yet was highly effective against GBM cells in culture and in tumors implanted into the flanks of mice. When targeted cranial RT was used to modulate the tumor BBB, the paclitaxel-loaded nanocarriers became effective against the intracranial tumors. Focused cranial RT improved DLN delivery into the intracranial tumors, significantly improving therapeutic outcomes. Tumor growth was delayed or halted, and survival was extended by >50% (p<0.05) compared to the results obtained with either RT or the DLN alone. Combinations of RT and chemotherapeutic agents linked to nanocarriers would appear to be an area for future investigations that could enhance outcomes in the treatment of human GBM. © Baumann et al.

References Powered by Scopus

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

17430Citations
N/AReaders
Get full text

Shape effects of filaments versus spherical particles in flow and drug delivery

2333Citations
N/AReaders
Get full text

Imaging in the era of molecular oncology

2165Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy

640Citations
N/AReaders
Get full text

Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges

242Citations
N/AReaders
Get full text

Selective Targeting of Brain Tumors with Gold Nanoparticle-Induced Radiosensitization

208Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Baumann, B. C., Kao, G. D., Mahmud, A., Harada, T., Swift, J., Chapman, C., … Dorsey, J. F. (2013). Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy. Oncotarget, 4(1), 64–79. https://doi.org/10.18632/oncotarget.777

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 30

77%

Researcher 6

15%

Professor / Associate Prof. 2

5%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 17

47%

Agricultural and Biological Sciences 10

28%

Engineering 5

14%

Biochemistry, Genetics and Molecular Bi... 4

11%

Save time finding and organizing research with Mendeley

Sign up for free